Author:
Vandecapelle Marleen,Slegers Guido,De Vos Filip,Dumont Filip
Publisher
Springer Berlin Heidelberg
Reference22 articles.
1. Andrée B, Halldin C, Pike VW, Gunn RN, Olsson H, Farde L (2002) The PET Radioligand [carbonyl-11C]desmethyl-WAY-100635 binds to 5-HT1A receptors and provides a higher radioactive signal than [carbonyl-11C]WAY-100635 in the human brain. J Nucl Med 43:292–303
2. Bergström KA, Meixiang Y, Kuikka JT, Âkerman KK, Hiltunen J, Lehtonen J, Halldin C, Tiihonen J (2000) Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography. Eur J Nucl Med 27:206–208
3. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099
4. Cliffe IA (2000) A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT1A receptor PET radioligand. Nucl Med Biol 27:441–447
5. Dichino DD, Welch MJ, Kilbourn MR, Raichle ME (1983) Relationship between lipophilicity and brain extraction of C-11 labeled radiopharmaceuticals. J Nucl Med 24:1030–1038